RO6870810 is a new drug being investigated as a treatment for myeloma and other cancers. It belongs to a class of drugs called Bromodomain and Extra-Terminal Protein (BET) Inhibitors.
|Developed By||Hoffmann-La Roche|
There are no resources, links or videos to display for this treatment.
SparkCures is working closely with Hoffmann-La Roche to provide the most up-to-date information on this treatment. Use the button above to add this treatment to your list of favorites.
Learn more about how we work with industry partners